Increasing the Ocrevus dose used in treating MS provided no additional benefit versus the approved regimen in trials with over 1,500 patients.

A lab study suggests cyclodextrins may help support myelin sheath repair in MS by reducing harmful fat buildup in immune cells.

An experimental MS therapy given as a nasal spray has started dosing its final participant in a Phase 2a trial of people with ...

MMR and chickenpox vaccines don't raise relapse risk for people with MS, a study found, supporting current vaccination ...

High-intensity physical exercise combined with melatonin supplements may offer more benefit to people with MS than either ...

Tolebrutinib has been approved in the European Union under the brand name Cenrifki for treating nonrelapsing secondary ...

Aspirin and acetaminophen may help ease MS fatigue, improve temperature regulation, and increase exercise capacity, a study ...

MS relapse risk was low after age 60 whether patients continued or stopped DMTs, but MRI changes were more common than ...

Supplementation with high-dose vitamin D for more than one year significantly reduced relapse risk and eased disability in ...

AI analysis of bacteria and other gut microorganisms can help distinguish between people with and without multiple sclerosis, ...

Researchers have identified six key proteins that could be targeted to combat MS progression, and potential drugs that could ...

Before her diagnosis, columnist Desiree Lama rarely questioned every sensation, but now she wonders if everything is a ...